Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulcrum Therapeutics (FULC) Cash & Current Investments: 2019-2025

Historic Cash & Current Investments for Fulcrum Therapeutics (FULC) over the last 7 years, with Sep 2025 value amounting to $200.6 million.

  • Fulcrum Therapeutics' Cash & Current Investments rose 176.26% to $200.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $882.4 million, marking a year-over-year increase of 102.61%. This contributed to the annual value of $241.0 million for FY2024, which is 2.03% up from last year.
  • Latest data reveals that Fulcrum Therapeutics reported Cash & Current Investments of $200.6 million as of Q3 2025, which was down 6.29% from $214.1 million recorded in Q2 2025.
  • Fulcrum Therapeutics' 5-year Cash & Current Investments high stood at $241.0 million for Q4 2024, and its period low was $30.1 million during Q3 2023.
  • In the last 3 years, Fulcrum Therapeutics' Cash & Current Investments had a median value of $86.7 million in 2024 and averaged $128.8 million.
  • In the last 5 years, Fulcrum Therapeutics' Cash & Current Investments plummeted by 66.93% in 2022 and then soared by 573.03% in 2023.
  • Quarterly analysis of 5 years shows Fulcrum Therapeutics' Cash & Current Investments stood at $35.4 million in 2021, then dropped by 0.89% to $35.1 million in 2022, then surged by 573.03% to $236.2 million in 2023, then climbed by 2.03% to $241.0 million in 2024, then surged by 176.26% to $200.6 million in 2025.
  • Its Cash & Current Investments was $200.6 million in Q3 2025, compared to $214.1 million in Q2 2025 and $226.6 million in Q1 2025.